HAUSMAN DIANA 4
4 · Zentalis Pharmaceuticals, Inc. · Filed May 9, 2024
Insider Transaction Report
Form 4
HAUSMAN DIANA
Director
Transactions
- Sale
Common Stock
2024-05-09$12.62/sh−3,356$42,353→ 373,876 total
Footnotes (1)
- [F1]This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person.